🔗 Share this article

This year's Nobel Prize in Physiology or Medicine has been awarded for transformative findings that clarify how the immune system attacks dangerous infections while protecting the body's own cells.

Three renowned scientists—from Japan Prof. Sakaguchi and US experts Mary Brunkow and Dr. Ramsdell—share this accolade.

The work identified unique "security guards" within the immune system that remove rogue defense cells capable of harming the organism.

The findings are now paving the way for innovative treatments for autoimmune diseases and cancer.

These winners will divide a monetary award valued at 11 million SEK.

Crucial Discoveries

"Their work has been decisive for comprehending how the body's defenses functions and why we don't all suffer from severe autoimmune diseases," stated the chair of the Nobel Committee.

This team's research explain a fundamental mystery: How does the defense system defend us from numerous invaders while leaving our own tissues unharmed?

The body's protection system employs white blood cells that search for signs of infection, including pathogens and germs it has never encountered.

These cells utilize sensors—called recognition units—that are produced by chance in countless variations.

That gives the immune system the capacity to combat a wide array of invaders, but the randomness of the process inevitably produces immune cells that may attack the body.

Protectors of the Immune System

Scientists previously knew that some of these problematic defense cells were destroyed in the immune organ—the site where white blood cells develop.

This year's Nobel Prize recognizes the discovery of regulatory T-cells—described as the immune system's "peacekeepers"—which travel through the body to neutralize any defenders that assault the healthy cells.

We know that this process fails in autoimmune diseases such as juvenile diabetes, multiple sclerosis, and RA.

The Nobel panel stated, "The discoveries have established a new field of investigation and spurred the creation of innovative therapies, for instance for cancer and autoimmune diseases."

In malignancies, regulatory T-cells prevent the system from attacking the growth, so research are aimed at reducing their numbers.

In self-attack disorders, experiments are testing increasing regulatory T-cells so the body is not under attack. A comparable method could also be effective in minimizing the risks of transplanted organ rejection.

Innovative Studies

Professor Shimon Sakaguchi, of a Japanese institution, conducted experiments on mice that had their immune gland extracted, leading to self-attack conditions.

He showed that introducing defense cells from other mice could stop the illness—suggesting there was a system for blocking immune cells from harming the host.

Mary Brunkow, affiliated with the a research center in Seattle, and Dr. Ramsdell, currently at a biotech firm in a California city, were investigating an genetic immune disorder in rodents and humans that resulted in the identification of a gene critical for how T-regs operate.

"The pioneering work has uncovered how the body's defenses is kept in check by T-reg cells, stopping it from mistakenly attacking the healthy cells," said a prominent biological science expert.

"This work is a remarkable example of how basic biological research can have broad consequences for human health."